Fatty liver disease, particularly its severe form called metabolic dysfunction-associated steatohepatitis (MASH), is a major precursor to liver cancer. Often triggered by high-fat, high-sugar diets, ...
In a series of studies at McMaster, Dr. Schertzer’s research group demonstrated that treatment with QBECO SSI resulted in a marked reduction in liver fat, inflammation, and fibrosis in fatty liver ...